Saturday, October 3, 2026

USD/EUR Over 2% Down In The Last 21 Sessions

ViaNews Editorial Team

February 2, 2023

USD/EUR Over 2% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.17% for the last 21 sessions. At 16:10 EST on Thursday, 2 February, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 5.31% up from its 52-week low and 12.593% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.15%, a negative 0.09%, and a positive 0.52%, respectively.

USD/EUR's highest amplitude of average volatility was 0.19% (last week), 0.42% (last month), and 0.52% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy price analysis: bears eye a test of 130.00 pre federal reserve. According to FXStreet on Tuesday, 31 January, "Meanwhile, the US Dollar rose on Monday, ahead of the Federal Reserve'stwo-day policy meeting which is likely to keep traders at bay and USD/JPY range bound until the outcome of the meeting. "
  • Usd/jpy portrays pre-fed anxiety, boj’s struggle to defend JGB yields around 130.00. According to FXStreet on Wednesday, 1 February, "It should be noted that downbeat US Treasury bond yields joined and firmer equity earnings and softer US data to renew the US Dollar weakness and strengthened the USD/JPY pullback.", "Looking ahead, multiple PMIs from China, Eurozone and the US may entertain the USD/JPY traders, as well as the JGB moves. "
  • Usd/jpy bulls hesitate around mid-130.00s as upbeat Japan data tease boj hawks. According to FXStreet on Tuesday, 31 January, "A daily closing beyond the 21-DMA level surrounding 130.35, the first early November 2021, keeps USD/JPY buyers hopeful.", "Additionally, China's inability to spread optimism after returning from the one-week-old Lunar New Year holiday, even with hopes of witnessing an end to the Covid wave, also favored the USD/JPY buyers."
  • Usd/jpy bulls hesitate around mid-130.00s as upbeat Japan data tease boj hawks. According to FXStreet on Tuesday, 31 January, "It should be noted that the cautious risk profile before the equity heavyweights like Amazon, Alphabet, Apple and Metal release their quarterly earnings, also underpinned the USD/JPY run-up the previous day.", "Additionally, China's inability to spread optimism after returning from the one-week-old Lunar New Year holiday, even with hopes of witnessing an end to the Covid wave, also favored the USD/JPY buyers."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com